Analyst Activity – JPMorgan Chase Reiterates Neutral on NVS – Novartis (NYSE:NVS)

Analyst Ratings For NVS – Novartis (NYSE:NVS)

Story continues below

Today, JPMorgan Chase reiterated its Neutral rating on NVS – Novartis (NYSE:NVS).

Some recent analyst ratings include

  • 4/9/2018-JPMorgan Chase Reiterated Rating of Neutral.
  • 1/2/2018-Nord/LB Reiterated Rating of Neutral.
  • 12/6/2017-Bank of America was Downgraded by analysts at Bank of America from a “Neutral ” rating to a ” Underperform” rating.
  • 10/25/2017-Barclays was Downgraded by analysts at Barclays from a “Equal Weight ” rating to a ” Underweight” rating.
  • 7/26/2017-Morgan Stanley Upgrade from a “Underweight ” rating to a ” Overweight” rating.

Dividend information for NVS – Novartis (NYSE:NVS)

NVS – Novartis (NYSE:NVS) pays an annual dividend of $2.98 with a yield of 3.69% and an average dividend growth of -0.50% based on a 3 Year Average..

Dividend History for NVS – Novartis (NYSE:NVS)

  • On 1/27/2017 NVS – Novartis announced a Annual dividend of $2.33 with an ex dividend date of 3/1/2017 which will be payable on 3/3/2017.
  • On 2/1/2016 NVS – Novartis announced a Annual dividend of $2.34 with an ex dividend date of 2/24/2016 which will be payable on 2/26/2016.
  • On 2/4/2014 NVS – Novartis announced a annual dividend of $2.72 3.48% with an ex dividend date of 2/27/2014 which will be payable on 3/11/2014.
  • On 2/11/2013 NVS – Novartis announced a annual dividend of $2.53 3.71% with an ex dividend date of 2/26/2013 which will be payable on 4/5/2013.

Recent Insider Trading Activity For NVS – Novartis (NYSE:NVS)
NVS – Novartis (NYSE:NVS) has insider ownership of 0.01% and institutional ownership of 10.76%.

  • On 7/5/2017 Bioventures Ltd Novartis, Major Shareholder, bought 266,667 with an average share price of $15.00 per share and the total transaction amounting to $4,000,005.00.
  • On 5/11/2016 Institutes For Biomed Novartis, Major Shareholder, bought 277,777 with an average share price of $18.00 per share and the total transaction amounting to $4,999,986.00.
  • On 2/17/2016 Bioventures Ltd Novartis, Major Shareholder, bought 375,000 with an average share price of $8.00 per share and the total transaction amounting to $3,000,000.00.
  • On 9/22/2014 Bioventures Ltd Novartis, Major Shareholder, bought 325,000 with an average share price of $15.00 per share and the total transaction amounting to $4,875,000.00.

Recent Trading Activity for NVS – Novartis (NYSE:NVS)
Shares of NVS – Novartis closed the previous trading session at 80.76 up +0.56 0.70% with 80.97000122070312 shares trading hands.

An ad to help with our costs